Full Text View
Tabular View
No Study Results Posted
Related Studies
Open-Label Pilot Study of Guanfacine-Extended Release for the Treatment of Cannabis Dependence (GUAN)
This study is currently recruiting participants.
Verified April 2013 by New York State Psychiatric Institute
Study NCT01467999   Information provided by New York State Psychiatric Institute

First Received on November 7, 2011.   Last Updated on April 18, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cannabis Dependence
Additional conditions recognized in this trial
Marijuana Abuse
More general conditions related to this trial
Mental Disorders
Substance-Related Disorders
Interventions listed in this trial
Guanfacine
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic Agonists
Adrenergic alpha-2 Receptor Agonists
Adrenergic alpha-Agonists
Antihypertensive Agents
Cardiovascular Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
New York State Psychiatric Institute


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services